NEW YORK and SAN DIEGO, Dec. 01, 2023 Zentalis® Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule.
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
In the realm of stock market movements, insider trading activity is often a significant indicator that investors monitor to gauge the confidence of management and key stakeholders in the company's future.
Wedbush lowered shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) from an outperform rating to a neutral rating in a research note released on Wednesday, MarketBeat reports. They currently have $12.00 price objective on the stock, down from their previous price objective of $38.00. Wedbush also issued estimates for Zentalis Pharmaceuticals’ Q4 2023 earnings at […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its target price reduced by HC Wainwright from $55.00 to $46.00 in a report published on Tuesday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Zentalis Pharmaceuticals’ Q4 2023 earnings at ($0.83) EPS, FY2023 earnings at ($4.44) EPS, […]